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Abstract
Age related Macular Degeneration
(AMD) is a disease of the retina that leads to
deterioration in vision and eventually permanent
blindness. As yet there are no definitive ways of
repairing the damage caused by AMD. Recently
evidence is mounting that cell-based therapy
using Retinal Pigment Epithelium (RPE) could
be a feasible option for treating this disease. For
example, autologous RPE transplantation has
been successful at providing a functioning
replacement for the diseased retina in animal
models and humans. However, degeneration can
re-occur requiring more RPE cells from the
patient. Therefore, considering the option of one-
time harvested RPE tissue from the periphery of
the patient’s eye, safe transportation between
clinics/hospitals, efficient in vitro RPE expansion
at the destination and long-term cryopreservation
for future applications, we have developed a
biodegradable RPE carrying medium in 3D,
made from a growth factor-free Thermo-
reversible gelation polymer (TGP - Mebiol gel).
RPE cell layers harvested from cadaver eyes
were embedded in the TGP hydrogel and divided
into three groups: Group 1, were processed
immediately, Group 2 after 18-24 hours and
Group 3 after 40-48 hrs of harvesting. Each group
had one control sub-group grown in conventional
media and one TGP sub-group grown embedded
in TGP scaffold. No growth factors were used in
the culture, when grown for three weeks. RPE
cell counts were done at regular intervals during
the expansion phase, and were then characterized
by RT-PCR to confirm their RPE phenotype. The
cells in all the three TGP preserved groups and
the controls were equally viable after different
periods of preservation, with a maximum
 Successful Transportation and in vitro Expansion of Human
Retinal Pigment Epithelium and its Characterization; A step
towards Cell-based Therapy for Age related Macular
Degeneration
Rajappa Senthilkumar2,3, Sadananda Rao Manjunath2,3, Subramani Baskar2,3, Vidyasagar
Devaprasad Dedeepiya2,3,  Sundaram Natarajan6, Sudhakar John2, Periyasamy Parikumar7,
Insaan Aditya8  Yuichi Mori4,  Hiroshi Yoshioka4   David W Green5,   Madasamy
Balamurugan9,   Shigeo Tsukahara1   and  Samuel JK Abraham 1,2*
1Yamanashi University, Faculty of Medicine, Chuo, Japan
2Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
3Dept. of Biotechnology, Acharya Nagarjuna University, Guntur, India
4Waseda University, Tokyo, Japan
5Faculty of Science, University of Technology, Sydney, Australia
6Aditya Jyot Eye Hospital, Mumbai, India
7The Light Eye Hospital, Dharmapuri, India
8Shah Satnamji Hospital, Sirsa, India
9Sri Lakshmi Narayana Institute of Medical Sciences, Pondicherry, India
        *For Correspondence - drabrahamsj@ybb.ne.jp
Human retinal pigment epithelium cultured in polymer scaffold for  AMD
Current Trends in Biotechnology and Pharmacy
Vol. 6 (1) 44-54 January 2012, ISSN 0973-8916 (Print), 2230-7303 (Online)
44
duration of 48 Hrs. In cultivation, TGP preserved
RPE cells formed a monolayer with a typical
honeycomb/cobblestone appearance characte-
ristic of native RPE. The degree of pigmentation
is increased in the TGP group compared to the
control group indicating that the RPE possesses
a native RPE phenotype. The proliferative
capacity of RPE was also increased when
embedded in TGP. Cells from both the groups
expressed Cellular Retinaldehyde-Binding
Protein (CRALBP) and RPE65, which are
abundantly expressed in the RPE cells and
Mueller cells of the retina. We have established
a simple and efficient transportation module for
RPE at varying climatic conditions without the
need for cool preservation using a polymer
hydrogel cocktail and a culture method without
using any growth factors. These cells can be a
potential source for transplantation in treating
retinal disorders upon further confirmation of
their functional characteristics.
Key words: Retinal pigment epithelium,
macular degeneration, hydrogel scaffold.
Introduction
The Retinal Pigment Epithelium (RPE) is
a neuroepithelium-derived, cellular monolayer
that lies on Bruch’s membrane between the
photoreceptor outer-segments and the
choriocapillaris. It serves to provide the
transducing interface for visual perception (1)
and hence is critical to providing vision (2). The
RPE is also important for local homeostasis and
maintenance of the extraphotoreceptor matrix.
Age  related  Macular  Degeneration
(AMD) is the third leading cause of worldwide
blindness in the elderly that results in a loss of
vision in the center of the visual field either due
to atrophy of the retinal pigment epithelial layer,
Dry Age related Macular Degeneration (Dry
AMD) or due to abnormal blood vessel growth,
Wet Age related Macular Degeneration (Wet
AMD) (3). The current treatments for wet AMD
include: photodynamic therapy (PDT), laser
therapy, anti-vascular endothelial growth factor
(anti-VEGF) therapy etc., all of which have
limited success and are non-permanent solutions.
For dry AMD there are not many options
available. The ideal treatment will be to replace
the dysfunctional RPE cells by cell-based
therapies which can repair the damaged retina
and restore normal vision. RPE transplantation
in humans was first performed in 1991 by
Peyman et al. but with little success (4). Later
allogenic fetal RPE cell transplantation was tried
in which, immune rejection of the graft was a
major issue. It was observed that rejection rates
were lower in dry AMD than wet AMD (5). In
many cases transplantation without
Immunosuppression therapy led to leakage on
fluorescein angiography and eventual fibrosis
(6). All these lead to the era of autologous RPE
transplantation which is conventionally done
employing two techniques namely retinal
pigment epithelial suspension and autologous
full-thickness retinal pigment epithelial-choroid
transplantation (7-11). Encouraging clinical
outcomes has already been reported with the
transplantation of the autologous RPE- Choroid
from the periphery of the eye to a disease affected
portion (10, 12, 13). Hurdles in autologous RPE
transplantation include, the RPE cells being
fragile when hit with surgical material, it is
impossible to transplant a layer uniformly and
in case of full-thickness transplantations
including  retinal pigment epithelial- Bruch’s
membrane- choroid transplantation, formation of
multilayered folds and contraction of the graft
pose as major hurdles (14). Also the option of
autologous graft is constrained by the size of the
full thickness RPE graft that can be taken from
the periphery of the same eye to patch the defect
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and this is usually insufficient. As a result, an
alternative source of cells to replace the diseased
RPE is needed (15). For this, we believe that a
safe, reproducible and efficient in vitro expansion
of the human RPE could be developed for the
clinic. Hence, there arises the need for a scaffold
material that will support RPE cells while culture
similar to a Bruch’s membrane, helping in fluid
transport with porosity and helps in
transplantation of RPE in the sub- retinal space
and is bio degradable. Recent approaches employ
the use of substrates like amniotic membrane (16
- 18). Singhal et al., has grown RPE cells
obtained from human cadaver eyes on human
Amniotic Membrane (hAM) as culture substrate
and reported that the Primary adult human RPE
cell cultures retain epithelial morphology in vitro
when cultured on human amniotic membranes.
However after the expansion, separation of the
RPE cell from amniotic membrane and
transferring of the expanded RPE cells without
contamination of amniotic membrane is difficult.
The use of feeder layers and growth factors are
another disadvantage, as a source of
contamination and immunoreactivity in the host.
 Herein, we report the transportation of
RPE tissue layers in a novel polymer based
transportation cocktail from hospitals to a central
processing facility without cool preservation
under varying climatic conditions and
subsequent isolation, expansion and
characterization of the RPE cells in a synthetic
biodegradable polymer scaffold without use of
growth factors.
Materials and Methods
Isolation of Retinal Pigment Epithelium:
Twelve RPE samples obtained from eyes of
human cadavers after proper informed consent
from the guardians were used in the study. These
RPE samples were obtained from three different
hospitals located at varying distances of 300 to
3000 kms from the central processing facility
taking a maximum time of 48 hrs. All the
procedures were in accordance with the
declaration of Helsinki and approved by the
Institutional ethical committees of the hospitals
involved in the study.
The RPE tissues were dissected and
embedded in Thermo Reversible Polymer based
cocktail by an experienced ophthalmologist.
Preparation of Transportation cocktail: The
transportation cocktail consisted of TGP
(Commercial name: Mebiol Gel) which is a
copolymer composed of thermo-responsive
polymer blocks [poly(N-isopropylacrylamide-
co-n-butyl methacrylate) poly(NIPAAm-co-
BMA)] and hydrophilic polymer blocks
[polyethylene glycol (PEG)]. The TGP is in
liquid state at lower than the sol-gel transition
temperature but turns to gel immediately upon
heating and returns to a liquid state again when
cooled. This sol-gel transition temperature can
be altered (19). The lyophilized TGP (1gm) vial
was provided for this study by Nichi-In
Biosciences (P) Ltd, Chennai, India. The TGP
was reconstituted with 10 ml of DMEM/F12
(Gibco BRL, Gaitherburg, MD, USA) and
incubated at 4°C overnight. 200 μl of
reconstituted TGP was added in each sterile vial
and the basal culture medium which need to be
overlaid contained 300μl of DMEM/F12 culture
medium without growth factors.
Transportation of RPE in TGP based cocktail :
The TGP vial was taken from the refrigerator
and the RPE tissue was embedded in the TGP in
the vial over which additional TGP kept under
cold condition was added and left undisturbed
for five minutes for the cold TGP to solidify.
After solidification of TGP, basal culture medium
described above was overlaid and the tissue
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containing vials were transported to the central
processing facility without cool preservation.
One RPE tissue was transported in one TGP vial.
Thus the RPE tissues embedded in TGP vials
were divided into three groups, Group 1, Group
2 and Group 3. RPE tissues in Group 1 were those
tissues which were processed within 18 hrs of
transport to the central processing facility, Group
2 contained RPE tissues which were processed
after 18-24 hours and Group 3 contained those
which were processed after 40 – 48 hours.
Tissue Processing: For tissue processing, the
RPE tissue transported in TGP vials were kept
in cold condition for the TGP to liquefy. All the
RPE tissues were subjected to washing by adding
cold Calcium Magnesium free CM-HBSS with
antibiotics (penicillin 50 U/ml, Streptomycin 0.1
mg/ml and Amphotericin B 0.0025 mg/ml) and
centrifugation at 1200 rpm for 10 minutes at 4 p
C using an ultra low temperature centrifuge.
After centrifugation, the supernatant was
discarded and the pellet was washed twice. The
washed RPE tissue pieces were subjected to
enzymatic digestion with 0.25% of Trypsin and
0.02% of EDTA for 10 minutes. After 10 minutes
of incubation, equivalent amount of Dulbecco’s
Modified Eagle’s medium (DMEM)/Ham F12
medium with 10% FBS was added to neutralize
the Trypsin activity. The cell suspension was
collected and centrifuged at 1200 rpm for 5
minutes. Cell count was done using Trypan Blue
Dye exclusion method. The cells obtained were
seeded equally in two groups for in vitro
expansion.
Control Group: The cell pellet was mixed in
Dulbecco’s Modified Eagle’s medium/Ham F12
medium supplemented with 10% Fetal Bovine
Serum and antibiotics (penicillin 50 U/ml,
Streptomycin 0.1 mg/ml and Amphotericin B
0.0025 mg/ml) in 24 well culture plates.
TGP Group: The cell pellet was plated in 24 well
culture plate containing TGP. Additional TGP
kept under cold conditions was added on top of
the cells and they were left undisturbed for 5
minutes for the cold TGP to solidify. DMEM/
Ham F12 medium supplemented with 10% Fetal
Bovine Serum and antibiotics (penicillin 50 U/
ml, Streptomycin 0.1 mg/ml and Amphotericin
B 0.0025 mg/ml) was overlaid on TGP after
solidification.
Both the groups were cultured for 21 Days
in 5% CO
2
 at 37°C and documented. Periodical
adding of culture medium and observation were
done in the same manner for both groups of
specimens.
Cell count and characterization of cultured
Retinal Pigment Epithelium: On the 21st day
the cells were harvested and subjected to cell
counting using tryphan blue exclusion method
and documented. The cultured RPE cells from
treated and un-treated groups (Control Group and
TGP Group) were subjected to H&E staining and
RT-PCR analysis. The total RNA content was
isolated from cultured Retinal Pigment Epithelial
Cells. Gene expression for major proteins
specific to the native RPE was confirmed using
RT-PCR specific primers such as RPE 65 which
is a RPE specific 65 kDa protein abundantly
expressed in the RPE cells and Mueller cells of
the retina (20) and Cellular Retinaldehyde-
Binding Protein (CRALBP) which is a 36-kD
water soluble protein and carries 11 cis-
retinaldehyde or 11 cis-retinal as physiological
ligands (21). GAPDH was used as control.
Results
The viability of the RPE tissues were well
maintained after transportation in the TGP based
preservation cocktail, and we could obtain an
average of 0.91 x106 cells after preservation for
a duration of 12- 48 hrs and the duration of
preservation did not have any statistically
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significant effect on the viability of the cells. The
Cells counts obtained after processing and
culture for 21 days are depicted in Table-1. The
RPE cell proliferation was higher in the TGP
group in majority (83.3%) of the specimens
(Graph 1). The TGP group had a 2.38 fold
increase in cells on an average whereas the
control group had a 2.17 fold increase (Graph
2). RPE Cells in TGP Group formed a monolayer,
showing  a  typical  honeycomb  appearance
(Fig.1) whereas in the Control Group these
characteristics were not observed. The cells in
the Control Group exhibited Glial cell like
morphology (Fig. 2), whereas in TGP Group the
cells resembled neuronal like spheres (Fig. 3).
The expression of pigments was better in TGP
Group compared to Control Group (Figs. 4, 5).
Fig. 1. In vitro expanded RPE cells in TGP group
showing honey comb morphology
Fig. 2. RPE cells in control group shows Glial Like cells
in vitro
Fig.3. In vitro expanded RPE cells in TGP group
exhibiting neuronal like spheres
Fig. 4. RPE cells showing relatively more pigmentation in TGP group (4B) when compared with control
group (4A) after 21 Days
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Histologically (H & E staining), dark pigmented
epithelial cells were observed in both the groups,
confirming the in vitro expanded cells to be RPE
cells. Large cells with large nuclei suggestive of
immature neuronal cells were observed in the
TGP group (Fig. 6). RT-PCR showed the
expression of the retinal pigment epithelial (RPE)
cells specific markers, Cellular Retinaldehyde-
Binding Protein (CRALBP) and retinal pigment
epithelial 65 (RPE65) in both the groups (Fig.7).
Discussion
The World Health organization (WHO)
states AMD to be the third leading cause of visual
impairment with nearly 9% of the world
population affected by this disorder (22) and the
prevalence is expected to double by 2020 (23).
Current therapeutic approaches to AMD include
thermal laser photocoagulation, surgical
approaches like excision or displacement, photo-
dynamic therapy and more recently anti-vascular
endothelial growth factor (VEGF) therapies.
However all these therapies aim to minimize
visual loss and optimize vision-related quality
of life (14). The search of an ideal therapeutic
approach that would help in regaining complete
vision, still continues in which, the approach of
RPE transplantation holds great promise.
Autologous RPE transplantation faces hurdles
such as (i) insufficient quantity of cells in the
graft and (ii) risk of biological contamination
with use of feeder layers, animal derived growth
factors for cell expansion and biological
scaffolds like amniotic membrane which have
Fig. 5. Inverted microscope images of the RPE cells during in vitro expansion:  A, B (Day
7) and C, D (Day 14)
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have accomplished the successful transportation
of RPE tissues in a novel Thermo-reversible
Gelation polymer (TGP) based transportation
cocktail from remote hospitals to a central
processing facility without cool preservation
under varying climatic conditions and using the
same polymer as a scaffold, subsequent isolation,
expansion and characterization of the human
retinal pigment epithelial cells without use of
growth factors.
We performed this study using TGP as a
3D scaffold for transportation and cell expansion
in vitro because TGP has shown to support the
culture of several cell types including corneal
Fig. 6. H&E staining of the in vitro expanded cells
show scattered dark pigmented epithelial cells. Large
cells with large nuclei suggestive of immature neu-
ronal cells are also seen.
Fig. 7: RT-PCR characteristics of the in vitro
expanded RPE Cells. Lane 1: 100 bp Ladder; Lane
2(control) : GAPDH  and CRALBP ;  Lane 3 (TGP)
: GAPDH  and CRALBP; Lane 4(control) : RPE65;
Lane 5(TGP): RPE65
an inherent threat of contamination after
transplantation. To our knowledge, an ideal
scaffold to support RPE cells for in vitro
expansion and to act as a carrier for
transplantation has not yet been reported. We
Graph 1. Comparison of RPE cell count after in vitro
expansion in Control Group vs TGP Group after
21 days
Table 1.  Cell count after in vitro expansion for 21
Days
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limbal stem cells (24), Hepatocytes (25),
Continuous Cell lines (26), chondrocytes (27),
neural cells (28) etc. TGP has already been
proven to preserve the cell viability of corneal
endothelial cells after transportation in varying
climatic conditions without cool preservation
(29). In this study, this result has been replicated
for RPE transportation. In addition cell viability
of the RPE tissues was maintained after
transportation in TGP and these cells could be
expanded substantially in vitro which is evident
by the higher fold increase of cells in the TGP
group compared to control group (Graph 2). The
transportation without cool preservation would
prove valuable in developing nations like India
where cold chain preservation in remote areas is
difficult.  Another major obstacle faced in the
culture of RPE is the loss of phenotype or de-
differentiation of the pigmented cells resulting
in loss of pigmentation. This loss of pigmentation
has been observed after sub-retinal
transplantation of the cultured RPE too (30). In
the present study, the ability of TGP to maintain
the phenotype of cultured RPE was confirmed
by the presence of neuronal spheres in TGP
Group which were not observed in Control
Group. Also the presence of intracellular
pigments was greater in TGP Group cultures
compared to Control Group. TGP provides a
three-dimensional tissue culture environment
that helps the cells to grow for longer period of
time without losing their viability (31). In many
studies on RPE culture, 3T3 feeder layers are
employed. Johnen et al. reported that when RPE
was cultured on 3T3 fibroblasts, RPE cells
exhibited stable expression of pigment epithelial
genes, but expression of mouse collagen type 1
was also observed (18) which is a disadvantage
for clinical translation.
The methodology employed in the present
study eliminates the need for growth factors or
feeder layers. When TGP is used as a substrate
for RPE cell culture and transplantation into the
sub retinal space, it could be advantageous
because the separation of cells from the substrate
is easy. There is no need for enzymatic digestion
to separate the cells due to the unique sol-gel
Graph 2. Comparison of Percentage of increase in RPE cell count between Control Group and TGP Group
    after 21 Days
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transition property of the TGP, which reverts into
liquid state when it is cooled. TGP has been
previously used by Sitalakshmi et al. in the
transplantation of corneal limbal stem cells into
the eyes of rabbits (24). TGP is biologically inert
(32) and biodegradable (33). Thus, TGP satisfies
most of the properties that is required for
successful RPE transplantation. This study has
established the utility of TGP for transport of
RPE tissues in a viable manner and its efficacy
to support RPE tissues in culture. Further studies
are needed to compare the functional
characteristics and post-transplantation efficacy
of allogenic RPE Vs autologous RPE
transplantation cultured in TGP scaffolds in
animal models before a clinical transplantation.
Sub-retinal space being an immunoprivileged
site, the allogenic RPE transplantation if proven
to be successful without any adverse reactions
would provide a simple and attractive new
solution. Thereby, the RPE tissues, which are
discarded once the corneal button is harvested
from cadaver eye, could be an indispensable
source of RPE cells for treating the AMD of
many patients.
Conclusion
We have established a simple and efficient
transportation modality of human cadaver donor
derived RPE tissues at varying climatic
conditions without cool preservation embedded
in a hydrogel cocktail and a methodology for in
vitro expansion of the RPE cells without using
any growth factors.  RPE cells showed better
growth characteristics in TGP even after
transportation at varying climatic conditions for
48 hours suggesting that TGP can be used as a
suitable substrate for both transportation and in
vitro expansion. The in vitro expanded RPE cells
using TGP could be a potential source of RPE
transplantation procedures for treating Age
related macular degeneration after confirmation
of their functional efficacy in animal models.
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